Actinium Pharmaceuticals, Inc. (ATNM) Net margin 2021–2025
Actinium Pharmaceuticals, Inc. (ATNM) net profit margin by fiscal year — reported net income divided by reported revenue.
-37652.2%FY2025 · since FY2021: -2165.6% → -37652.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -37652.2% | — |
| FY2023 | -60269.1% | -57063.6 pp |
| FY2022 | -3205.5% | -1040.0 pp |
| FY2021 | -2165.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATNM financial trends
ATNM RevenueATNM Net incomeATNM Gross profitATNM Gross marginATNM Operating incomeATNM Operating marginATNM Operating cash flowATNM Free cash flowATNM Capital expendituresATNM Return on equityATNM Stock buybacksATNM Dividends paidATNM Total assetsATNM Total liabilitiesATNM Shareholders’ equityATNM overview →